Loading insider details...
Latest Form 4 (Jun 17, 2026): Sale of 3,000,000 CAVA shares, $270.90M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | CAVA GROUP, INC. (CAVA) | Sale | 3,000,000 | $270.90M |
| May 9, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Exercise/Conversion | 20,421,735 | n/a |
| Feb 19, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 41,290 | $2.68M |
| Feb 4, 2026 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/Award | 18,553,846 | $24.12M |